Skip to main content

Ethicon Physiomesh Lawsuits To Face Trial In April 2020

Ethicon Physiomesh Lawsuits To Face Trial In April 2020

Ethicon Physiomesh Lawsuits To Face Trial In April 2020

Introduction

The U.S District judge presiding in the Northern District of Georgia indicated that all federal Ethicon Physiomesh lawsuits will face their first bellwether trial involving the recalled hernia mesh in April 2020. 

As part of the bellwether process designed, it will help parties to gauge how jurors will respond to certain evidence and testimony, which is likely to be repeated throughout thousands of claims brought by the individuals.

Ethicon physiomesh is a multi-layered, flexible composite hernia mesh product introduced by J&J’s Ethicon subsidiary in 2010. Currently, there are more than 2,000 product liability lawsuits over Ethicon Physiomesh pending in the federal court system, each raising similar allegations that the drugmaker sold a defective and dangerous product which caused plaintiff with severe abdominal pain, infection, hernia recurrence, adhesions, perforations, erosion and other injuries associated with a hernia mesh failure.

The federal cases are centralized for pretrial proceedings before US District Judge Richard Story in the Northern District of Georgia as part of MDL. (MDL no. 2782), to avoid duplicative discovery, conflicting rulings from different courts and to serve the convenience of parties.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!